The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.

Nebivolol is known to have beta-1 blocker activity, but it was also suggested that it elicits relaxation of the peripheral arteries in part via release of nitric oxide (NO). However, the effect of nebivolol on the vasomotor tone of cerebral arteries is still unclear.To assess the effects of nebivolo...

Full description

Bibliographic Details
Main Authors: Peter Cseplo, Zoltan Vamos, Ivan Ivic, Orsolya Torok, Attila Toth, Akos Koller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5055296?pdf=render
id doaj-406750ab45c245b9ba58c3ef1e3bc510
record_format Article
spelling doaj-406750ab45c245b9ba58c3ef1e3bc5102020-11-24T21:30:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016401010.1371/journal.pone.0164010The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.Peter CseploZoltan VamosIvan IvicOrsolya TorokAttila TothAkos KollerNebivolol is known to have beta-1 blocker activity, but it was also suggested that it elicits relaxation of the peripheral arteries in part via release of nitric oxide (NO). However, the effect of nebivolol on the vasomotor tone of cerebral arteries is still unclear.To assess the effects of nebivolol on the diameter of isolated rat basilar arteries (BA) in control, in the presence of inhibitors of vasomotor signaling pathways of know action and hemolysed blood.Vasomotor responses were measured by videomicroscopy and the intracellular Ca2+ by the Fura-2 AM ratiometric method. Under control conditions, nebivolol elicited a substantial dilation of the BA (from 216±22 to 394±20 μm; p<0.05) in a concentration-dependent manner (10-7 to 10-4 M). The dilatation was significantly reduced by endothelium denudation or by L-NAME (inhibitor of NO synthase) or by SQ22536 (adenylyl cyclase blocker). Dilatation of BA was also affected by beta-2 receptor blockade with butoxamine, but not by the guanylate cyclase blocker ODQ. Interestingly, beta-1 blockade by atenolol inhibited nebivolol-induced dilation. Also, the BKCa channel blocker iberiotoxin and KCa channel inhibitor TEA significantly reduced nebivolol-induced dilation. Nebivolol significantly reduced smooth muscle Ca2+ level, which correlated with the increases in diameters and moreover it reversed the hemolysed blood-induced constriction of BA.Nebivolol seems to have an important dilator effect in cerebral arteries, which is mediated via several vasomotor mechanisms, converging on the reduction of smooth muscle Ca2+ levels. As such, nebivolol may be effective to improve cerebral circulation in various diseased conditions, such as hemorrhage.http://europepmc.org/articles/PMC5055296?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Peter Cseplo
Zoltan Vamos
Ivan Ivic
Orsolya Torok
Attila Toth
Akos Koller
spellingShingle Peter Cseplo
Zoltan Vamos
Ivan Ivic
Orsolya Torok
Attila Toth
Akos Koller
The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
PLoS ONE
author_facet Peter Cseplo
Zoltan Vamos
Ivan Ivic
Orsolya Torok
Attila Toth
Akos Koller
author_sort Peter Cseplo
title The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
title_short The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
title_full The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
title_fullStr The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
title_full_unstemmed The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
title_sort beta-1-receptor blocker nebivolol elicits dilation of cerebral arteries by reducing smooth muscle [ca2+]i.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Nebivolol is known to have beta-1 blocker activity, but it was also suggested that it elicits relaxation of the peripheral arteries in part via release of nitric oxide (NO). However, the effect of nebivolol on the vasomotor tone of cerebral arteries is still unclear.To assess the effects of nebivolol on the diameter of isolated rat basilar arteries (BA) in control, in the presence of inhibitors of vasomotor signaling pathways of know action and hemolysed blood.Vasomotor responses were measured by videomicroscopy and the intracellular Ca2+ by the Fura-2 AM ratiometric method. Under control conditions, nebivolol elicited a substantial dilation of the BA (from 216±22 to 394±20 μm; p<0.05) in a concentration-dependent manner (10-7 to 10-4 M). The dilatation was significantly reduced by endothelium denudation or by L-NAME (inhibitor of NO synthase) or by SQ22536 (adenylyl cyclase blocker). Dilatation of BA was also affected by beta-2 receptor blockade with butoxamine, but not by the guanylate cyclase blocker ODQ. Interestingly, beta-1 blockade by atenolol inhibited nebivolol-induced dilation. Also, the BKCa channel blocker iberiotoxin and KCa channel inhibitor TEA significantly reduced nebivolol-induced dilation. Nebivolol significantly reduced smooth muscle Ca2+ level, which correlated with the increases in diameters and moreover it reversed the hemolysed blood-induced constriction of BA.Nebivolol seems to have an important dilator effect in cerebral arteries, which is mediated via several vasomotor mechanisms, converging on the reduction of smooth muscle Ca2+ levels. As such, nebivolol may be effective to improve cerebral circulation in various diseased conditions, such as hemorrhage.
url http://europepmc.org/articles/PMC5055296?pdf=render
work_keys_str_mv AT petercseplo thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT zoltanvamos thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT ivanivic thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT orsolyatorok thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT attilatoth thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT akoskoller thebeta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT petercseplo beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT zoltanvamos beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT ivanivic beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT orsolyatorok beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT attilatoth beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
AT akoskoller beta1receptorblockernebivololelicitsdilationofcerebralarteriesbyreducingsmoothmuscleca2i
_version_ 1725964187929149440